Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor

Molecular Brain Research

Volumn 40, Issue 1, 1996, Pages 116-126

  Barger, Steven W ^a   Mattson, Mark P ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Antisense; Calcium; cGMP; Free radical; I B MAD3; NF B; Tumor necrosis factor; amyloid precursor protein

Indexed keywords

AMYLOID BETA PROTEIN; CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLIC GMP; LYMPHOTOXIN; PROTEIN PRECURSOR;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; NERVE CELL; NEUROPROTECTION; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DNA BINDING; REPORTER GENE;

EID: 0030222080     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(96)00036-8     Document Type: Article

References (60)

1. [1] Barger, S.W., Fiscus, R.R., Ruth, P., Hofmann, F. and Mattson, M.P., The role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor, J. Neurochem., 64 (1995) 2087-2096.
2. 2- accumulation, Proc. Natl. Acad. Sci. USA, 92 (1995) 9328-9332.
3. [3] Barger, S.W. and Mattson, M.P., Involvement of NF-κB in neuroprotective genetic programs, Soc. Neurosci. Abstr., 20 (1994) 687.
4. [4] Barger, S.W. and Mattson, M.P., Excitatory amino acids and growth factors: biological and molecular interactions regulating neuronal survival and plasticity. In T.W. Stone (Ed.), CNS Neurotransmitters and Neuromodulators, CRC Press, Boca Raton, 1995.
5. [5] Bondy, S.C. and LeBel, C.P., The relationship between excitotoxicity and oxidative stress in the central nervous system, Free Radic. Biol. Med., 14 (1993) 633-642.
6. [6] Butt, E., van Bemmelen, M., Fischer, L., Walter, U. and Jastorff, B., Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates, FEBS Lett., 263 (1990) 47-50.
7. [7] Cheng, B., Christakos, S. and Mattson, M.P., Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis, Neuron, 12 (1994) 139-153.
8. [8] Cogswell, P.C., Scheinman, R.I. and Baldwin, A.S., Jr., Promoter of the human NF-κB p50/p105 gene. Regulation by NF-κB subunits and by c-REL, J. Immunol., 150 (1993) 2794-2804.
9. [9] Coyle, J.T. and Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders, Science, 262 (1993) 689-694.
10. [10] Culcasi, M., Lafon-Cazal, M., Pietri, S. and Bockaert, J., Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons, J. Biol. Chem., 269 (1994) 12589-12593.
11. [11] de Martin, R., Vanhove, B., Cheng, Q., Hofer, E., Csizmadia, V., Winkler, H. and Bach, F.H., Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NFκB, EMBO J., 12 (1993) 2773-2779.
12. [12] Elliott, E.M. and Sapolsky, R.M., Corticosterone impairs hippocampal neuronal calcium regulation - possible mediating mechanisms, Brain Res., 602 (1993) 84-90.
13. [13] Friedman, W.J., Thakur, S. and Rabson, A.B., Induction of NFκB mediates regulation of nerve growth factor mRNA by IL-1 in rat hippocampal astrocytes, Soc. Neurosci. Abstr., 21 (1995) 1045.
14. [14] Furukawa, K., Barger, S.W., Blalock, E.M. and Mattson, M.P., Activation of potassium channels and suppression of neuronal activity by secreted β-amyloid precursor protein, Nature, 379 (1996) 74-78.
15. [15] Ghosh, S. and Baltimore, D., Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB, Nature, 344 (1990) 678-682.
16. [16] Gilmore, T.D. and Morin, P.J., The IκB proteins: members of a multifunctional family, Trends Genet., 9 (1993) 427-433.
17. 2 and cyclic GMP, Immunobiology, 182 (1990) 44-55.
18. [18] Goodman, Y. and Mattson, M.P., Secreted forms of β amyloid precursor protein protect hippocampal neurons against β-peptide toxicity and oxidative injury, Exp. Neurol., 128 (1994) 1-12.
19. [19] German, C.M., Moffat, L.F. and Howard, B.H., Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells, Mol. Cell. Biol., 2 (1982) 1044-1051.
20. [20] Griffin, W.S.T., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White, C.L.I. and Araoz, C., Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease, Proc. Natl. Acad. Sci. USA, 86 (1989) 7611-7615.
21. [21] Grilli, M., Chiu, J.J.-S. and Lenardo, M.J., NF-κB and Rel: participants in a multiform transcriptional regulatory system, Int. Rev. Cytol., 143 (1993) 1-62.
22. [22] Guerrini, L., Blasi, F. and Denis-Donini, S., Activation of NFκB upon glutamate stimulation in cultured mouse cerebellar granule cells, Soc. Neurosci. Abstr., 20 (1994) 1510.
23. [23] Haby, C., Lisovoski, F., Aunis, D. and Zwiller, J., Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and junB in PC12 cells, J. Neurochem., 62 (1994) 496-501.
24. [24] Henkel, T., Machleidt, T., Alkalay, I., Kronke, M., Ben-Neriah, Y. and Baeuerle, P.A., Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB, Nature, 365 (1993) 182-185.
25. [25] Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H. and Bensi, G., Characterization of a functional NF-κB site in the human interleukin 1β promoter: evidence for a positive autoregulatory loop, Mol. Cell. Biol., 13 (1993) 6231-6240.
26. [26] Jin, L.W., Ninomiya, H., Roch, J.M., Schubert, D., Masliah, E., Otero, D.A. and Saitoh, T., Peptides containing the RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension, J. Neurosci., 14 (1994) 5461-5470.
27. [27] Kaltschmidt, B., Baeuerle, P.A. and Kaltschmidt, C., Potential involvement of the transcription factor NF-κB in neurological disorders, Mol. Aspects Med., 14 (1993) 171-190.
28. [28] Kaltschmidt, C., Kaltschmidt, B. and Baeuerle, P.A., Brain synapses contain inducible forms of the transcription factor NF-κB, Mech. Dev., 43 (1993) 135-147.
29. [29] Kang, S.M., Tran, A.C., Grilli, M. and Lenardo, M.J., NF-κB subunit regulation in nontransformed CD + T lymphocytes, Science, 256 (1992) 1452-1456.
30. 2+ conductances: relevance to brain aging, Proc. Natl. Acad. Sci. USA, 89 (1992) 8527-8531.
31. [31] Kim, H.T., Kim, Y.H., Nam, J.W., Lee, H.J., Rho, H.M. and Jung, G., Study of 5′-flanking region of human Cu/Zn superoxide dismutase, Biochem. Biophys. Res. Commun., 201 (1994) 1526-1533.
32. [32] Korner, M., Rattner, A., Mauxion, F., Sen, R. and Citri, Y., A brain-specific transcription activator, Neuron, 3 (1989) 563-572.
33. [33] Korner, M., Tarantino, N., Pleskoff, O., Lee, L.M. and Debre, P., Activation of nuclear factor κB in human neuroblastoma cell lines, J. Neurochem., 62 (1994) 1716-1726.
34. [34] Lafon-Cazal, M., Pietri, S., Culcasi, M. and Bockaert, J., NMDA-dependent superoxide production and neurotoxicity, Nature, 364 (1993) 535-537.
35. [35] Landfield, P.W., Nathan Shock Memorial Lecture 1990. The role of glucocorticoids in brain aging and Alzheimer's disease: an integrative physiological hypothesis, Exp. Gerontol., 29 (1994) 3-11.
36. [36] Le Bail, O., Schmidt-Ullrich, R. and Israel, A., Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family, EMBO J., 12 (1993) 5043-5049.
37. [37] Mattson, M.P. and Barger, S.W., Programmed cell life: neuroprotective signal transduction and ischemic brain injury. In M.A. Moskowitz and L.R. Caplan (Eds.), Cerebrovascular Diseases: Nineteenth Princeton Stroke Conference, Butterworth-Heinemann, Boston, 1995.
38. [38] Mattson, M.P., Barger, S.W., Begley, J. and Mark, R.J., Calcium, free radicals, and excitotoxic neuronal death in primary cell culture, Meth. Cell Biol., 46 (1995) 187-216.
39. [39] Mattson, M.P., Barger, S.W., Cheng, B., Lieberburg, I., Smith-Swintosky, V.L. and Rydel, R.E., β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci., 16 (1993) 409-414.
40. [40] Mattson, M.P. and Cheng, B., Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis, Stroke, 24 (Suppl.) (1993) 1136-1140.
41. [41] Mattson, M.P., Cheng, B., Culwell, A.R., Esch, F.S., Lieberburg, I. and Rydel, R.E., Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein, Neuron, 10 (1993) 243-254.
42. i and neurotoxicity, and increase antioxidant enzyme activities in hippocampal neurons, J. Neurochem., 65 (1995) 1740-1751.
43. [43] Mittal, C.K. and Murad, F., Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3′.5′-monophosphate formation, Proc. Natl. Acad. Sci. USA. 74 (1977) 4360-4364.
44. [44] Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S. and Kasahara, T., Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-κB is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem., 269 (1994) 13289-13295.
45. [45] Murphy, M., Friend, D.S., Pike-Nobile, L. and Epstein, L.B., Tumor necrosis factor-α and IFN-γ expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21), J. Immunol., 149 (1992) 2506-2512.
46. [46] Ostrowski, J., Sims, J.E., Sibley, C.H., Valentine, M.A., Dower, S.K., Meier, K.E. and Bomsztyk, K., A serine/threonine kinase activity is closely associated with a 65-kDa phosphoprotein specifically recognized by the κB enhancer element, J. Biol. Chem., 266 (1991) 12722-12733.
47. [47] Page, B., Page, M. and Noel, C., A new fluorometric assay for cytotoxicity measurements in vitro, Int. J. Oncol., 3 (1993) 473-476.
48. [48] Palombella, V.J., Rando, O.J., Goldberg, A.L. and Maniatis, T., The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB, Cell, 78 (1994) 773-785.
49. [49] Pang, X.P., Ross, N.S., Park, M., Juillard, G.J., Stanley, T.M. and Hershman, J.M., Tumor necrosis factor-α activates nuclear factor κB and induces manganous superoxide dismutase and phosphodiesterase mRNA in human papillary thyroid carcinoma cells, J. Biol. Chem., 267 (1992) 12826-12830.
50. [50] Peunova, N. and Enikolopov, G., Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells, Nature, 364 (1993) 450-453.
51. [51] Ray, A. and Prefontaine, K.E., Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor, Proc. Natl. Acad. Sci. USA, 91 (1994) 752-756.
52. [52] Saitoh, T., Sundsmo, M, Roch, J.-M., Ximura, M., Cole, G., Schubert, D., Oltersdorf, T. and Schenk, D.B., Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts, Cell, 58 (1989) 615-622.
53. [53] Schmitz, M.L. and Baeuerle, P.A., The p65 subunit is responsible for the strong transcription activating potential of NF-κB, EMBO J., 10 (1991) 3805-3817.
54. [54] Schreck, R., Rieber, P. and Baeuerle, P.A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1, EMBO J., 10 (1991) 2247-2258.
55. [55] Selkoe, D.J., Normal and abnormal biology of the β-amyloid precursor protein, Annu. Rev. Neurosci., 17 (1994) 489-517.
56. [56] Shakhov, A.N., Collart, P.V., Vassalli, P., Nedospasov, S.A. and Jongeneel, C.V., κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages, J. Exp. Med., 171 (1990) 35-47.
57. [57] Shirakawa, F., Chedid, M., Suttles, J., Pollok, B.A. and Mizel, S.B., Interleukin 1 and cyclic AMP induce κ immunoglobulin light-chain expression via activation of an NF-κB-like DNA-binding protein, Mol. Cell. Biol., 9 (1989) 959-964.
58. [58] Sun, S.C., Ganchi, P.A., Ballard, D.W. and Greene, W.C., NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway, Science, 259 (1993) 1912-1915.
59. [59] Tombaugh, G.C. and Sapolsky, R.M., Endocrine features of glucocorticoid endangerment in hippocampal astrocytes, Neuroendocrinology, 57 (1993) 7-13.
60. [60] Yamamoto, K., Miyoshi, T., Yae, T., Kawashima, K., Araki, H., Hanada, K., Otero, D.A., Roch, J.M. and Saitoh, T., The survival of rat cerebral cortical neurons in the presence of trophic APP peptides, J. Neurobiol., 25 (1994) 585-594.